Physicochemical Properties
| Molecular Formula | C22H26BRFN4O6S2 |
| Molecular Weight | 605.50 |
| CAS # | 1646361-04-7 |
| Related CAS # | Morphothiadin;1092970-12-1 |
| SMILES | C1(=C(C=CC(=C1)F)C1C(C(OCC)=O)=C(CN2CCOCC2)N=C(C2SC=CN=2)N1)Br.S(=O)(C)(O)=O |
| Synonyms | GLS4 mesylate |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Effects of ketoconazole and rifampicin on the pharmacokinetics of GLS4, a novel anti-hepatitis B virus compound, in dogs. Acta Pharmacol Sin. 2013 Nov;34(11):1420-6. [2]. Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly. Antimicrob Agents Chemother. 2013 Nov;57(11):5344-54. |
Solubility Data
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6515 mL | 8.2576 mL | 16.5153 mL | |
| 5 mM | 0.3303 mL | 1.6515 mL | 3.3031 mL | |
| 10 mM | 0.1652 mL | 0.8258 mL | 1.6515 mL |